RT @SeekingTruth4us: @backtolife_2023 https://t.co/wZyDCZZ5FX Phase 3 median survival was only 19.3 months vs 16.5 due to low response rate…

@backtolife_2023 https://t.co/wZyDCZZ5FX Phase 3 median survival was only 19.3 months vs 16.5 due to low response rates, Not even FDA approved-yet they charge 6 figures regardless while repurposed-natural agents https://t.co/r0xkEOFvXS suppressed🤔👇https://

RT @metacollectiveG: $NWBO #NWBO @statnews Who’re you going to believe?

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @albtur_mnymkrs: Doctors love #dcvax $nwbo

RT @metacollectiveG: $NWBO #NWBO @statnews Who’re you going to believe?

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

@bradloncar Northwest Biotherapeutics, DCVax platform. With DCVax-L P3 trial data just released on JAMA. https://t.co/MKzPI1oCCd

#DCVax $nwbo #GBM https://t.co/8tKGOQ09tO https://t.co/7kAS5IwKCG

RT @MC17595091: #DCVax $nwbo #GBM #CancerResearch https://t.co/8tKGOPZBEg

#DCVax $nwbo #GBM #CancerResearch https://t.co/8tKGOPZBEg

@columbiacancer No tweet or PR? https://t.co/AW4ElUAoiG “6 Columbia University Irving Medical Center, New York, New York”

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @Dave46217976: $NWBO #DCVAX

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

$NWBO #DCVAX

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

$NWBO #NWBO @statnews Who’re you going to believe?

Trust the doctors. $nwbo #dcvax

RT @Nina_kd: $NWBO more physicians will be spreading the news like wild fire to each other and to their patients of this newly revolutionar…

RT @HenryMuney: From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for pati…

From @DrSimonKhagi MD, FACP, co-author of the #DCVax-L Phase 3 trial results, "Seldom do we see promising advances for patients with #braincancer. But this is one of those moments that gives these patient's hope!" 1. https://t.co/RWpX1lyMZx 2. https://t.c

RT @albtur_mnymkrs: Doctors love #dcvax $nwbo

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

Doctors love #dcvax $nwbo

RT @eastvillagetwt: $NWBO #DCVaxL #CancerVaccine For the hedge fund short who complains that supplemental materials are missing, he just h…

$NWBO Adam Feuerstein, because shorts gotta cover. https://t.co/AW4ElUAoiG

RT @ilyassahinMD: 2- ~20 yıldır ilk kez, yeni teşhis edilmiş glioblastomada sistemik bir tedavi için bir faz 3 çalışmasında bu kadar önemli…

$NWBO not selling. I doubt any longs are selling. We have some aggressive short hedge funds and Adam Feuerstein against a huge number of top research centers, doctors, a peer reviewed journal article, non-profit patient advocates and patients and one Nobel

$NWBO #DCVaxL #CancerVaccine For the hedge fund short who complains that supplemental materials are missing, he just has to click the icons along the top of the article to get them. So much FUD. One day of FUD can’t outrun success. https://t.co/AW4ElU

RT @eastvillagetwt: @sharpie510 “Treatment with DCVax-L can potentially be combined with a wide range of other treatment agents (including…

@Kennydoesbio https://t.co/8tKGOPZBEg

RT @albtur_mnymkrs: Reporting done right! $nwbo thanks you @NeuroscienceNew

RT @Dave46217976: #DCVAX $NWBO

@bradloncar $NWBO https://t.co/6IU9tkEdjK

@bradloncar https://t.co/b2SL7ngfR4

$nwbo https://t.co/64lwmFBpWr

RT @Dave46217976: #DCVAX #GBM #CancerVaccine #NoSideEffects $NWBO

RT @NicholasBlondin: “The mOS for patients with nGBM assigned to the DCVax-L cohort at enrollment was 19.3 months from the time of randomiz…

RT @NeuroscienceNew: “Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients Wi…

RT @ilyassahinMD: 2- ~20 yıldır ilk kez, yeni teşhis edilmiş glioblastomada sistemik bir tedavi için bir faz 3 çalışmasında bu kadar önemli…

RT @NeuroscienceNew: “Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients Wi…

2- ~20 yıldır ilk kez, yeni teşhis edilmiş glioblastomada sistemik bir tedavi için bir faz 3 çalışmasında bu kadar önemli sonuçlar elde edildi. Ve uzun yıllar sonra ilk kez herhangi bir tedavi tekrarlayan glioblastomada sağkalımı uzattığı gösterildi.✅ htt

RT @ChenyuLinMD: Phase III trial of $NWBO #DCVax-L showed promising benefits to OS in relapsed and new MGMT-methylated #glioblastoma. 13% s…

RT @NeuroscienceNew: “Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients Wi…

RT @NeuroscienceNew: “Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients Wi…

RT @NeuroscienceNew: “Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients Wi…

Reporting done right! $nwbo thanks you @NeuroscienceNew

@statnews https://t.co/eZV7ULNYQk

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

“Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma” by Linda M. Liau et al. JAMA Oncology https://t.co/PY9ObT0NPX

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

RT @medical_xpress: Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5…

Phase 3 clinical trial: #Braincancer #vaccine shows promising results @kingscollegelon @JAMAOnc https://t.co/DhvH0QxlN5 https://t.co/OdCvOrPN0i

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @PathologyPat: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With N…

RT @JonksStonks: Dr. Linda Liau https://t.co/F3W3UYnnZb Enough said.

@cure_today @Midatech @MDAndersonNews @DukeCancer https://t.co/0yGiQfe8z7 More options and real HOPE coming down the pipeline. #dcvax $nwbo

@matthewherper Do better, Matt. STAT is becoming no more than a tabloid with this AF trash. https://t.co/b2SL7ngfR4

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

RT @Nina_kd: $NWBO more physicians will be spreading the news like wild fire to each other and to their patients of this newly revolutionar…

RT @DrFerdowsi: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With New…

Okay, $NWBO pumper; let's look at what Dr. Liau says in the @JAMAOnc interview, and readers can decide if it's true or not. 🧵This screenshot is her exact explanation: https://t.co/GDA7PSJvLa https://t.co/OOveHE2eaz

RT @DrFerdowsi: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With New…

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

RT @Nina_kd: $NWBO more physicians will be spreading the news like wild fire to each other and to their patients of this newly revolutionar…

Congratulations to our @DrSimonKhagi and his collaborators on the publication of this important study in @JAMAOnc. https://t.co/LROvCwR9zy

$NWBO more physicians will be spreading the news like wild fire to each other and to their patients of this newly revolutionary DCVaxL to treating cancer with no side effects that increase life longevity!

@MidwestHedgie Linda Liau herself says so on the JAMA interview. Under the"play" icon tab. Are you implying she's lying? We all know you and your buddy AF know it's a success, you just want to deny it by all means. https://t.co/mHbUEV7iQc

@Dereklowe Ex vivo pulsed dendritic cell based "vaccines" certainly don't seem to have much promise but I wouldn't lump all cancer vaccine strategies into that same category The paper for those out of the loop https://t.co/VLGDqph7zk

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @PathologyPat: Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With N…

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @FlemmingBruce: $NWBO Just hand her that goddamn prize!!!

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma | JAMA Oncology | JAMA Network https://t.co/3RUk3HHRua

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

RT @yachtmastter: Hey @statnews - in case you didn't know, #JAMA stands for Journal of the American Medical Association. You'd be wise to r…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…

RT @AlMusella: @JoeBiden @DrBiden did you see the news about breakthrough in glioblastoma treatment? Dcvax. https://t.co/sowFiBVVhA we ne…